Investor Relations

Sunshine Heart is a global medical technology company, committed to the commercialization of C-Pulse®, an implantable, non-blood contacting, heart assist therapy for the treatment of people with class III and ambulatory class IV heart failure. Sunshine Heart is listed on the NASDAQ Capital Market.

Press Releases

Posted on Apr 24, 2017
EDEN PRAIRIE, Minn., April 24, 2017 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today the closing of an underwritten public offering of units for gross proceeds of $9.2 million, which includes the full exercise of the underwriter's over-allotment option to purchase additional s...

Read More

Posted on Apr 19, 2017
EDEN PRAIRIE, Minn., April 19, 2017 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today the pricing of an underwritten public offering of units for gross proceeds of $8.0 million, prior to deducting underwriting discounts and commissions and offering expenses payable by Sunshine ...

Read More

Posted on Apr 11, 2017
EDEN PRAIRIE, Minn., April 11, 2017 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today that on April 24, 2017, Jim Breidenstein will join the Company as Chief Commercial Officer. In this capacity, Mr. Breidenstein will be responsible for all commercial operations of the Company....

Read More

Events & Presentations

Posted on Mar 2, 2017 at 9:00 AM ET
Posted on Nov 8, 2016 at 9:00 AM ET
Posted on Aug 24, 2016 at 11:45 AM CT